Portage Biotech Stock Surges 68.43% in Third Consecutive Day of Gains, Trading Volume Ranks 328th

On April 11, 2025, Portage Biotech (PRTG) experienced a significant surge, with its stock price rising by 68.43%, marking the third consecutive day of gains and a cumulative increase of 75.31% over the past three days. The trading volume for the day was 3.03 billion, placing it at the 328th position in terms of trading volume for the day.

Portage Biotech is actively developing several innovative treatments, including PORT-4, a nanolipogel co-formulation aimed at treating solid tumors, which is currently in preclinical trials. Additionally, the company is working on PORT-5, a VLP-STING treatment, and has reported promising preclinical results for PORT-7 in the treatment of mesothelioma. These developments support the initiation of a first-in-human trial for PORT-7, highlighting the company's progress in advancing its pipeline of therapeutic candidates.